LSDI Lucy Scientific Discovery
WatchlistLucy Scientific Discovery News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersDare Bioscience (NASDAQ:DARE) shares rose 31.1% to $0.46 during Thursday's pre-market session. The company's market cap stands at $44.8 million. Anixa Biosciences (NASDAQ:ANIX) shares moved upw
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersPhio Pharma (NASDAQ:PHIO) stock increased by 33.9% to $1.5 during Wednesday's pre-market session. The company's market cap stands at $3.6 million. Tenax Therapeutics (NASDAQ:TENX) shares moved
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersPhio Pharma (NASDAQ:PHIO) shares moved upwards by 19.6% to $1.34 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. Lucy Scientific Discover
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAllarity Therapeutics (NASDAQ:ALLR) shares rose 44.0% to $0.86 during Tuesday's pre-market session. The company's market cap stands at $3.9 million. Sonoma Pharmaceuticals (NASDAQ:SNOA) stock r
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersEyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 378.8% to $31.65 during Monday's pre-market session. The company's market cap stands at $1.1 billion. Alterity Therapeutics (NASDAQ:ATH
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) shares increased by 46.4% to $0.3 during Friday's after-market session. The market value of their outstanding shares is at $5.2 million. Lexeo Therapeuti
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersIntelligent Bio Solutions (NASDAQ:INBS) stock increased by 33.3% to $0.3 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 979.5K shares, whi
12 Health Care Stocks Moving In Monday's After-Market Session
GainersSenti Biosciences (NASDAQ:SNTI) shares increased by 187.7% to $0.84 during Monday's after-market session. Trading volume for this security closed at 4.9 million, accounting for 1643.6% of its a
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts Jada Pinkett Smith has joined the growing number of Hollywood celebs who are sharing difficult ment
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
Psychedelics company Lucy Scientific Discovery Inc. (NASDAQ:LSDI) reported its full-year results for the period ended June 30, 2023. Numbers show: Total cash held of $1.67 million, vs. $53,379 held i
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE:CYBN) and UK-based Small Pharma Inc. (OTC:DMTTF) held their re
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company B
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 369 companies hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Coca-Cola (NYSE:KO).The smallest
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 311 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Bristol-Myers Squibb Company Common Stock (NYSE:BMY) is the largest company in terms of market cap to set
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of psychedeli
Psychedelic Drugs Market to Break $7B in 2029 Led by These 3 Meds
Psychedelics Research Amendments Advance in House Committee
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge Billionaire hedge fund and NY Mets owner, Steve Cohen amped up his support for psychedelics R&D
Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth
From Instagram to High Times: Unpacking the Power of Vast User Networks
NetworkNewsWire Editorial Coverage NEW YORK, Sept. 19, 2023 /PRNewswire/ -- In the business world, one of the cardinal reasons for mergers and acquisitions (M&As) is the potential for synergistic growth. Successful